Literature DB >> 22237388

Trends in death attributed to heart failure over the past two decades in Europe.

Said Laribi1, Albertine Aouba, Maria Nikolaou, Johan Lassus, Alain Cohen-Solal, Patrick Plaisance, Gérard Pavillon, Preeti Jois, Gregg C Fonarow, Eric Jougla, Alexandre Mebazaa.   

Abstract

AIMS: Little is known regarding temporal trends in mortality attributed to heart failure (HF) from a population perspective. The aim of this study was to assess the mortality related to HF as an underlying cause during the last 20 years in seven European countries. METHODS AND
RESULTS: The number of deaths with HF as the underlying cause was collected in seven European states: Germany, Greece, England and Wales, Spain, France, Finland, and Sweden from 1987 to 2008. Disease coding for HF was based on the International Classification of Diseases (ICD 9th and 10th versions). We computed age-standardized death rates (SDRs) per 100 000 inhabitants. Mean age at death from HF was also calculated for the same period. In the seven studied countries, the HF SDR decreased continuously from 54.2 (1987) to 32.6 (2008). Despite differences in the early 1990s, SDRs related to HF seemed to converge, in these seven European countries, to ∼30 deaths per 100 000 population in the near future, for both men and women. During the study period, the mean age at death increased from 80.0 to 82.7 years. Half of the deaths from HF occurred in hospital, without change over time.
CONCLUSION: There has been a 40% reduction of the SDR due to HF in seven European countries during two decades and a concomitant increase in the mean age at death from HF. We hypothesize that these results may be related to a better management of chronic and acute HF patients over the past 20 years.

Entities:  

Mesh:

Year:  2012        PMID: 22237388     DOI: 10.1093/eurjhf/hfr182

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  33 in total

1.  Patient-Associated Predictors of 15- and 30-Day Readmission After Hospitalization for Acute Heart Failure.

Authors:  Juan F Delgado; Andreu Ferrero Gregori; Laura Morán Fernández; Ramón Bascompte Claret; Andrés Grau Sepúlveda; Francisco Fernández-Avilés; José R González-Juanatey; Rafael Vázquez García; Miguel Rivera Otero; Javier Segovia Cubero; Domingo Pascual Figal; Maria G Crespo-Leiro; Jesús Alvarez-García; Juan Cinca; Fernando Arribas Ynsaurriaga
Journal:  Curr Heart Fail Rep       Date:  2019-12

Review 2.  Left ventricular strain and twisting in heart failure with preserved ejection fraction: an updated review.

Authors:  Marijana Tadic; Elisabeth Pieske-Kraigher; Cesare Cuspidi; Martin Genger; Daniel A Morris; Kun Zhang; Nina Alexandra Walther; Burket Pieske
Journal:  Heart Fail Rev       Date:  2017-05       Impact factor: 4.214

3.  Serelaxin, a 'breakthrough' investigational intravenous agent for acute heart failure.

Authors:  Marta A Miyares; Kyle A Davis
Journal:  P T       Date:  2013-10

Review 4.  The emerging role of epigenetics in cardiovascular disease.

Authors:  Charbel Abi Khalil
Journal:  Ther Adv Chronic Dis       Date:  2014-07       Impact factor: 5.091

5.  Effects of sauna bath on heart failure: A systematic review and meta-analysis.

Authors:  Miikka Källström; Inga Soveri; Jonas Oldgren; Jari Laukkanen; Tomoko Ichiki; Chuwa Tei; Mark Timmerman; Lars Berglund; Hans Hägglund
Journal:  Clin Cardiol       Date:  2018-11-21       Impact factor: 2.882

Review 6.  Relaxin for treatment of acute heart failure: making the case for treating targeted patient profiles.

Authors:  Jaime A Hernandez-Montfort; Sonali Arora; Mara T Slawsky
Journal:  Curr Heart Fail Rep       Date:  2013-09

7.  Plasma galectin 3 and heart failure risk in the Physicians' Health Study.

Authors:  Luc Djoussé; Chisa Matsumoto; Andrew Petrone; Natalie L Weir; Michael Y Tsai; J Michael Gaziano
Journal:  Eur J Heart Fail       Date:  2013-12-04       Impact factor: 15.534

Review 8.  New and old technologies for organ replacement.

Authors:  Jeffrey L Platt; Marilia Cascalho
Journal:  Curr Opin Organ Transplant       Date:  2013-04       Impact factor: 2.640

9.  Temporal trends in treatment and outcomes for advanced heart failure with reduced ejection fraction from 1993-2010: findings from a university referral center.

Authors:  John C Loh; Julie Creaser; Darlene A Rourke; Nancy Livingston; Tamara K Harrison; Elizabeth Vandenbogaart; Jaime Moriguchi; Michele A Hamilton; Chi-Hong Tseng; Gregg C Fonarow; Tamara B Horwich
Journal:  Circ Heart Fail       Date:  2013-03-11       Impact factor: 8.790

Review 10.  Effects of biological sex on the pathophysiology of the heart.

Authors:  Loubina Fazal; Feriel Azibani; Nicolas Vodovar; Alain Cohen Solal; Claude Delcayre; Jane-Lise Samuel
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.